| Therapeutic class/Medication | N | Percentage |
| Methotrexate | 35 | 71.4 |
| Corticosteroids (prednisone, methylprednisolone) | 30 | 61.2 |
| Anti TNF-α (Adalimumab, Etanercept) | 22 | 44.9 |
| Anti-IL-6R (Tocilizumab) | 9 | 18.4 |
| Hydroxychloroquine | 7 | 14.3 |
| Other immunosuppressant drug (Mycophenolate, Cyclophosphamide) | 5 | 10.2 |
| Anti CD20 MCA (Rituximab) | 5 | 10.2 |
| IVIG | 2 | 4.1 |
| Folic acid | 22 | 44.9 |
| NSAIDs | 10 | 20.4 |